Skip To Main Content
Nonhlanhla N. Mkhize on Muck Rack

Nonhlanhla N. Mkhize

As seen in: Nature, PLOS, PLOS Medicine, Eyewitness News, Journal of Infection
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Nonhlanhla N.

Contact Nonhlanhla N., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARSCoV2 infection in Africa

|
By Referenced By, Nonhlanhla N. Mkhize, Shuying Li
| wits.ac.za
Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARSCoV2 infection in Africa
Open in Who Shared Issue with article?

Neutralizing and Binding Antibodies are a Correlate of Risk of COVID19 in the CoVPN 3008 Study in People with HIV

|
By Referenced By, Nonhlanhla N. Mkhize, B Zhang
| wits.ac.za
Neutralizing and Binding Antibodies are a Correlate of Risk of COVID19 in the CoVPN 3008 Study in People with HIV
Open in Who Shared Issue with article?

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

|
By Carolyn Williamson, Chivonne Moodley, Craig A Magaret, Elena Giorgi, Morgane Rolland, Dylan Westfall, Anna Yssel, Wenjie Deng, Nonhlanhla N. Mkhize, Lennie Chen, Hong Zhao, Tanmoy Bhattacharya, Alec Pankow, Ben Murrell, Ruwayhida Thebus, Paula Cohen Verified, Bronwen E. Lambson, Michal Juraska, Hongjun Bai, Allan C. deCamp, Maurine D Miner, James Ludwig, Yunda Huang, Lily Zhang, Daniel Reeves, Bryan Mayer, Shelly Karuna, John Hural, Lynn Morris, David C. Montefiori, Penny Moore, Paul T. Edlefsen, Srilatha Edupuganti, Nyaradzo Mgodi, M. Juliana McElrath, Myron Cohen, Lawrence Corey, Peter Gilbert, James Mullins, Raabya Rossenkhan, Talita York, Asanda Gwashu-Nyangiwe, Nonkululeko Ndabambi, Haajira Kaldine, Sinethemba Bhebhe, Cindy Molitor, Nicolas Beaume, David Matten, Roger E. Bumgarner
| Nature Verified
Abstract In the antibody mediated prevention (AMP) trials, the broadly neutralizing antibody (bNAb) VRC01 demonstrated protective efficacy against susceptible HIV strains. To understand how VRC01 shaped breakthrough infections, deep sequencing was performed on 172 participants (>100,000 gag-Δpol and rev-env-Δnef sequences), at diagnosis and over time, in the placebo and treatment arms of the African (HVTN703/HPTN081; NCT02568215) and Americas/Europe (HVTN704/HPTN085; NCT02716675) cohorts.
Open in Who Shared Issue with article?
See all 10 articles